CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Pfizer Inc. v. Par Pharmaceutical, Inc.

1:17-cv-00342

Overview

Case Number 1:17-cv-00342
Filing Date 2017-03-30
Status Litigation filed
Court ded
Nature of Suit 830 Patent

Parties

Defendant

Par Pharmaceutical, Inc.

Represented By

5 Attorneys Listed

Steven J. Fineman

Richards, Layton & Finger, PA

Tel: +1 (302) 658-6541

Richards, Layton & Finger, PA, One Rodney Square

Ricardo S. Camposanto

Email: rcamposanto@axinn.com

Katharine Lester Mowery

Richards, Layton & Finger, PA

Tel: +1 (302) 651-7623

Richards, Layton & Finger, PA, One Rodney Square

David H. Silverstein

Email: dsilverstein@axinn.com

Aziz Burgy

Email: aburgy@axinn.com

Plaintiff

Pfizer Ireland Pharmaceuticals

Represented By

2 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Pfizer Limited

Represented By

2 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Pfizer Inc.

Represented By

2 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

ded

Patents Involved

No asserted patent numbers detected in initial docket filings yet.

Docket Entries

COMPLAINT filed against Par Pharmaceutical, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2112729.) - filed by Pfizer Limited, Pfizer Inc., Pfizer Ireland Pharmaceuticals. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(sar) (Entered: 03/30/2017)

2017-03-30
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sar) (Entered: 03/30/2017)

2017-03-30
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 2/14/2017. Date of Expiration of Patent: 10/9/2018.Thirty Month Stay Deadline: 8/14/2019. (sar) (Entered: 03/30/2017)

2017-03-30
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,124,363;. (sar) (Entered: 03/30/2017)

2017-03-30
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc